A citation-based method for searching scientific literature

Arkadiy K Golov, Nikolay V Kondratyev, George P Kostyuk, And Vera E Golimbet. Cells 2020
Times Cited: 6







List of co-cited articles
8 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Relationship between muscarinic M1 receptor binding and cognition in medication-free subjects with psychosis.
Geor Bakker, Claudia Vingerhoets, Daphne Boucherie, Matthan Caan, Oswald Bloemen, Jos Eersels, Jan Booij, Thérèse van Amelsvoort. Neuroimage Clin 2018
11
33

The muscarinic system, cognition and schizophrenia.
Sean P Carruthers, Caroline T Gurvich, Susan L Rossell. Neurosci Biobehav Rev 2015
55
33

Classics in Chemical Neuroscience: Xanomeline.
Aaron M Bender, Carrie K Jones, Craig W Lindsley. ACS Chem Neurosci 2017
18
33


The density of muscarinic M1 receptors is decreased in the caudate-putamen of subjects with schizophrenia.
B Dean, J M Crook, K Opeskin, C Hill, N Keks, D L Copolov. Mol Psychiatry 1996
119
33

Selective muscarinic receptor agonist xanomeline as a novel treatment approach for schizophrenia.
Anantha Shekhar, William Z Potter, Jeffrey Lightfoot, John Lienemann, Sanjay Dubé, Craig Mallinckrodt, Frank P Bymaster, David L McKinzie, Christian C Felder. Am J Psychiatry 2008
293
33

Elucidating the role of muscarinic receptors in psychosis.
C C Felder, A C Porter, T L Skillman, L Zhang, F P Bymaster, N M Nathanson, S E Hamilton, J Gomeza, J Wess, D L McKinzie. Life Sci 2001
86
33

A global reference for human genetic variation.
Adam Auton, Lisa D Brooks, Richard M Durbin, Erik P Garrison, Hyun Min Kang, Jan O Korbel, Jonathan L Marchini, Shane McCarthy, Gil A McVean, Gonçalo R Abecasis. Nature 2015
33


Current status of muscarinic M1 and M4 receptors as drug targets for neurodegenerative diseases.
Christian C Felder, Paul J Goldsmith, Kimberley Jackson, Helen E Sanger, David A Evans, Adrian J Mogg, Lisa M Broad. Neuropharmacology 2018
29
16


Muscarinic receptors as a target for drugs treating schizophrenia.
Frank P Bymaster, Christian Felder, Saeed Ahmed, David McKinzie. Curr Drug Targets CNS Neurol Disord 2002
81
16

Low levels of muscarinic M1 receptor-positive neurons in cortical layers III and V in Brodmann areas 9 and 17 from individuals with schizophrenia.
Elizabeth Scarr, Shaun Hopper, Valentina Vos, Myoung Suk Seo, Ian Paul Everall, Timothy Douglas Aumann, Gursharan Chana, Brian Dean. J Psychiatry Neurosci 2018
14
16

Widespread decreases in cortical muscarinic receptors in a subset of people with schizophrenia.
Andrew Stuart Gibbons, Elizabeth Scarr, Simone Boer, Tammie Money, Won-Je Jeon, Chris Felder, Brian Dean. Int J Neuropsychopharmacol 2013
40
16

Increased baseline occupancy of D2 receptors by dopamine in schizophrenia.
A Abi-Dargham, J Rodenhiser, D Printz, Y Zea-Ponce, R Gil, L S Kegeles, R Weiss, T B Cooper, J J Mann, R L Van Heertum,[...]. Proc Natl Acad Sci U S A 2000
673
16


Xanomeline, an M(1)/M(4) preferring muscarinic cholinergic receptor agonist, produces antipsychotic-like activity in rats and mice.
H E Shannon, K Rasmussen, F P Bymaster, J C Hart, S C Peters, M D Swedberg, L Jeppesen, M J Sheardown, P Sauerberg, A Fink-Jensen. Schizophr Res 2000
103
16



Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors.
H E Shannon, F P Bymaster, D O Calligaro, B Greenwood, C H Mitch, B D Sawyer, J S Ward, D T Wong, P H Olesen, M J Sheardown,[...]. J Pharmacol Exp Ther 1994
121
16

Decreased cortical muscarinic receptors define a subgroup of subjects with schizophrenia.
E Scarr, T F Cowie, S Kanellakis, S Sundram, C Pantelis, B Dean. Mol Psychiatry 2009
91
16

Altered M(1) muscarinic acetylcholine receptor (CHRM1)-Galpha(q/11) coupling in a schizophrenia endophenotype.
Hasib Salah-Uddin, Elizabeth Scarr, Geoffrey Pavey, Kriss Harris, Jim J Hagan, Brian Dean, R A John Challiss, Jeannette M Watson. Neuropsychopharmacology 2009
35
16

Muscarinic acetylcholine receptor subtypes: localization and structure/function.
M R Brann, J Ellis, H Jørgensen, D Hill-Eubanks, S V Jones. Prog Brain Res 1993
68
16

Differential regulation of molecular subtypes of muscarinic receptors in Alzheimer's disease.
D D Flynn, G Ferrari-DiLeo, D C Mash, A I Levey. J Neurochem 1995
189
16

M4 muscarinic receptors regulate the dynamics of cholinergic and dopaminergic neurotransmission: relevance to the pathophysiology and treatment of related CNS pathologies.
Eleni T Tzavara, Frank P Bymaster, Richard J Davis, Mark R Wade, Kenneth W Perry, Jurgen Wess, David L McKinzie, Chris Felder, George G Nomikos. FASEB J 2004
110
16


Evolutionary Expansion of Human Cerebellar Germinal Zones.
Matthew G Keefe, Tomasz J Nowakowski. Trends Neurosci 2020
3
33

Differential brain glucose metabolic patterns in antipsychotic-naïve first-episode schizophrenia with and without auditory verbal hallucinations.
Guillermo Horga, Eduard Parellada, Francisco Lomeña, Emilio Fernández-Egea, Anna Mané, Mireia Font, Carles Falcón, Anna B Konova, Javier Pavia, Domènec Ros,[...]. J Psychiatry Neurosci 2011
18
16

Strategies for Advancing Disease Definition Using Biomarkers and Genetics: The Bipolar and Schizophrenia Network for Intermediate Phenotypes.
Carol A Tamminga, Godfrey D Pearlson, Ana D Stan, Robert D Gibbons, Jaya Padmanabhan, Matcheri Keshavan, Brett A Clementz. Biol Psychiatry Cogn Neurosci Neuroimaging 2017
28
16

Investigation of m1/m4 muscarinic receptors in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression disorder.
Katerina Zavitsanou, Andrew Katsifis, Filomena Mattner, Xu-Feng Huang. Neuropsychopharmacology 2004
100
16

A selective allosteric potentiator of the M1 muscarinic acetylcholine receptor increases activity of medial prefrontal cortical neurons and restores impairments in reversal learning.
Jana K Shirey, Ashley E Brady, Paulianda J Jones, Albert A Davis, Thomas M Bridges, J Phillip Kennedy, Satyawan B Jadhav, Usha N Menon, Zixiu Xiang, Mona L Watson,[...]. J Neurosci 2009
168
16

Acetylcholine in mind: a neurotransmitter correlate of consciousness?
E Perry, M Walker, J Grace, R Perry. Trends Neurosci 1999
515
16

Muscarinic1 and 2 receptor mRNA in the human caudate-putamen: no change in m1 mRNA in schizophrenia.
B Dean, J M Crook, G Pavey, K Opeskin, D L Copolov. Mol Psychiatry 2000
42
16



The potent M1 receptor allosteric agonist GSK1034702 improves episodic memory in humans in the nicotine abstinence model of cognitive dysfunction.
Pradeep J Nathan, Jeannette Watson, Jesper Lund, Ceri H Davies, Gary Peters, Chris M Dodds, Bridget Swirski, Philip Lawrence, Graham D Bentley, Barry V O'Neill,[...]. Int J Neuropsychopharmacol 2013
67
16

Localization of the motor hand area to a knob on the precentral gyrus. A new landmark.
T A Yousry, U D Schmid, H Alkadhi, D Schmidt, A Peraud, A Buettner, P Winkler. Brain 1997
16


The muscarinic M1/M4 receptor agonist xanomeline exhibits antipsychotic-like activity in Cebus apella monkeys.
Maibritt B Andersen, Anders Fink-Jensen, Linda Peacock, Jes Gerlach, Frank Bymaster, Jens August Lundbaek, Thomas Werge. Neuropsychopharmacology 2003
58
16

Muscarinic receptor binding changes in postmortem Parkinson's disease.
Caitlin McOmish, Geoff Pavey, Catriona McLean, Malcolm Horne, Brian Dean, Elizabeth Scarr. J Neural Transm (Vienna) 2017
7
16



Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia.
S G Fillman, N Cloonan, V S Catts, L C Miller, J Wong, T McCrossin, M Cairns, C S Weickert. Mol Psychiatry 2013
333
16

Muscarinic M1 receptor sequence: preliminary studies on its effects on cognition and expression.
Elizabeth Scarr, Suresh Sundram, Azita Deljo, Tiffany Francis Cowie, Andrew Stuart Gibbons, Susan Juzva, Andrew Mackinnon, Stephen J Wood, Renee Testa, Christos Pantelis,[...]. Schizophr Res 2012
15
16

Changes in BQCA Allosteric Modulation of [(3)H]NMS Binding to Human Cortex within Schizophrenia and by Divalent Cations.
Brian Dean, Shaun Hopper, P Jeffrey Conn, Elizabeth Scarr. Neuropsychopharmacology 2016
17
16

Benefits and limits of anticholinergic use in schizophrenia: focusing on its effect on cognitive function.
Shin Ogino, Seiya Miyamoto, Nobumi Miyake, Noboru Yamaguchi. Psychiatry Clin Neurosci 2014
41
16

Association of muscarinic m1 receptor genetic polymorphisms with psychiatric symptoms and cognitive function in schizophrenic patients.
Ding-Lieh Liao, Chen-Jee Hong, Hong-Mei Chen, Yueh-Er Chen, Shin-Min Lee, Chun-Yi Chang, Hong Chen, Shih-Jen Tsai. Neuropsychobiology 2003
48
16

An investigation of the factors that regulate muscarinic receptor expression in schizophrenia.
Myoung Suk Seo, Elizabeth Scarr, Brian Dean. Schizophr Res 2014
7
16


Widespread Changes in Positive Allosteric Modulation of the Muscarinic M1 Receptor in Some Participants With Schizophrenia.
Shaun Hopper, Geoffrey Mark Pavey, Andrea Gogos, Brian Dean. Int J Neuropsychopharmacol 2019
5
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.